Telix and radioisotope maker ITM merge in deal worth up to $2.35B

Telix Pharmaceuticals is buying German radioisotope manufacturer ITM Isotope Technologies Munich SE for $1.65 billion upfront, but some deal milestones hinge on a recently rejected drug. The merger will combine ITM’s commercial radioisotope manufacturing with ...